Four Taiwanese employees of Foxconn, also known as Hon Hai Precision Industry, the primary assembly partner of Apple Inc.

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Astellas has turned to AviadoBio to further boost its gene therapy pipeline, paying the British biotech $50 million in equity ...

Astellas has added another gene therapy to its pipeline, taking an option on a clinical-stage candidate for a rare genetic ...

Astellas will fund research until completion of a phase 1 trial for each candidate. At that point Astellas and Adaptimmune will decide whether to progress with co-marketing of each candidate.

The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront ...

Proprietary cell-free platform enables the design of next-generation ADCs intended to broaden addressable patient populationsSTRO-004 (tissue ...

Cambridge’s Camp4 Therapeutics Inc. and Waltham’s Upstream Bio Inc. will both make their debuts on the public markets Friday.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") announced that VEOZA™ (fezolinetant)*, its first-in-class treatment for moderate to severe vasomotor symptoms (VMS) ...

AviadoBio and Astellas Pharma announced an exclusive option and license agreement for AVB-101, an investigational, AAV-based gene ...

Bank of Ireland, Aldi and drinks giants Coca-Cola and Diageo were among the big winners at the second Menopause Workplace ...